Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Weitere Synonyme anzeigen
Human Polyclonal MTOR Primary Antibody für IF (p), IHC (p) - ABIN676403
Li, Liu, Wang, Sun, Ding, Sun, Han, Wang: Follistatin could promote the proliferation of duck primary myoblasts by activating PI3K/Akt/mTOR signalling. in Bioscience reports 2014
Show all 6 Pubmed References
Human Polyclonal MTOR Primary Antibody für ELISA, EM - ABIN153493
Gupta, Dillon, Ziesmer, Feldman, Witzig, Ansell, Cerhan, Novak: A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation. in Blood 2009
Show all 5 Pubmed References
Human Polyclonal MTOR Primary Antibody für ICC, IF - ABIN151707
Bolster, Vary, Kimball, Jefferson: Leucine regulates translation initiation in rat skeletal muscle via enhanced eIF4G phosphorylation. in The Journal of nutrition 2004
Show all 4 Pubmed References
Human Polyclonal MTOR Primary Antibody für DB - ABIN1881353
Dowling, Zakikhani, Fantus, Pollak, Sonenberg: Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. in Cancer research 2007
Show all 4 Pubmed References
Human MTOR Primary Antibody für IHC - ABIN966602
Holz, Blenis: Identification of S6 kinase 1 as a novel mammalian target of rapamycin (mTOR)-phosphorylating kinase. in The Journal of biological chemistry 2005
Show all 3 Pubmed References
Human Polyclonal MTOR Primary Antibody für IHC (p), WB - ABIN272127
Li, Yan, Zhang, Jiang, Sun, Hu, Sun, Xu: miR-145 inhibits isoproterenol-induced cardiomyocyte hypertrophy by targeting the expression and localization of GATA6. in FEBS letters 2013
Show all 3 Pubmed References
Human Polyclonal MTOR Primary Antibody für IF (p), IHC (p) - ABIN747158
Yang, Wang, Wang, Zhang, Zhang, Lu, Wang: mTOR is involved in 17?-estradiol-induced, cultured immature boar Sertoli cell proliferation via regulating the expression of SKP2, CCND1, and CCNE1. in Molecular reproduction and development 2015
Show all 2 Pubmed References
Human Polyclonal MTOR Primary Antibody für IF, IHC - ABIN362262
Albanell, Dalmases, Rovira, Rojo: mTOR signalling in human cancer. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2007
Show all 3 Pubmed References
Human Polyclonal MTOR Primary Antibody für IHC, ELISA - ABIN1531910
Luo, Yoneda, Ohmori, Sasaki, Shimbo, Eto, Kato, Miyano, Kobayashi, Sasahira, Chihara, Kuniyasu: Cancer usurps skeletal muscle as an energy repository. in Cancer research 2014
Human Polyclonal MTOR Primary Antibody für ICC, IF - ABIN447030
Bennett, Stockley, Fleming, Mandal, OPrey, Ryan, Robson, Leung: Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells? in BJU international 2013
the present study showed that tetrandrine induced autophagy in human bladder cancer cells by regulating the AMPK (zeige PRKAA1 Antikörper)/mTOR signaling pathway, which contributed to the apoptosis induction by tetrandrine, indicating that tetrandrine may be a potential anticancer candidate for the treatment of bladder cancer, and autophagy may be a possible mechanism for cancer therapy.
mTORC1 or mTORC2 (zeige CRTC2 Antikörper) silencing markedly decreases the plasma membrane expression of FR-alpha (zeige FOLR1 Antikörper) and RFC (zeige RFC1 Antikörper) transporter isoforms without affecting global protein expression
In vivo overexpression of iASPP (zeige PPP1R13L Antikörper) in SCID (zeige PRKDC Antikörper)/NOD mice promoted tumorigenesis and autophagy, with an increase in the conversion from LC3 (zeige MAP1LC3A Antikörper)-I to LC3 (zeige MAP1LC3A Antikörper)-II. The effects of iASPP (zeige PPP1R13L Antikörper) were mediated through activation of mTOR pathway.
Studies indicate that understanding mTOR network circuitry will provide insight into its deregulation in diabetes, cancer, and cardiovascular disease, but modeling in silico to elucidate how insulin (zeige INS Antikörper) activates mTORC2 (zeige CRTC2 Antikörper) remains poorly defined.
Results show that mTOR expression level is dowregulated in non-small cell lung cancer (NSCLC) and that its protein phosphylation level is down when NSCLC cells are transfected with miR (zeige MLXIP Antikörper)-145.
These results indicate that Merlin (zeige NF2 Antikörper)/YAP (zeige YAP1 Antikörper)/cMyc (zeige MYC Antikörper)/mTOR signaling axis promotes human cholangiocarcinoma (CCA (zeige FBN2 Antikörper)) cell proliferation by overriding contact inhibition. We propose that overriding cMycmediated contact inhibition is implicated in the development of CCA (zeige FBN2 Antikörper).
This study showed that the mTOR pathway is activated in a high proportion of hereditary pheochromocytomas (PCCs) and paragangliomas (PGLs (zeige PGLS Antikörper) with a preferential overactivation of the mTORC1 complex in PGLs (zeige PGLS Antikörper) of the head and neck and/or harboring SDHX mutations.
that AKT and mTOR proteins are involved in oral squamous cell carcinoma biology and that GSK3beta itself may drive cervical lymph node metastatic spread of oral squamous cell carcinoma cells
Targeting PPT1 (zeige PPT1 Antikörper) blocks mTOR signaling in a manner distinct from catalytic inhibitors, while concurrently inhibiting autophagy, thereby providing a new strategy for cancer therapy.
miRNA-101 level is decreased in RCC (zeige XRCC1 Antikörper) tissues/cells, which could be responsible for DNA-PKcs (zeige PRKDC Antikörper) overexpression and DNA-PKcs (zeige PRKDC Antikörper) mediated oncogenic actions; DNA-PKcs (zeige PRKDC Antikörper) over-expression regulates mTORC2 (zeige CRTC2 Antikörper)-AKT (zeige AKT1 Antikörper) activation, HIF-2alpha (zeige EPAS1 Antikörper) expression and RCC (zeige XRCC1 Antikörper) cell proliferation
Ggpps (zeige GGPS1 Antikörper) deletion enhanced Rheb (zeige RHEB Antikörper) farnesylation, which subsequently activated mTORC1 and facilitated spermatogonial differentiation
mTOR is crucial for T-cell accumulation in the GI tract and for establishing local adaptive immunity against pathogens.
Data show that mammalian/mechanistic target of rapamycin (mTOR) perturbation alters the suprachiasmatic nucleus (SCN (zeige SRI Antikörper)) clock oscillations.
These data demonstrate that the activated mTOR by Erk1/2 results in energy consumption, which in turn leads to endoplasmic reticulum stress signaling and thus induces apoptosis in high glucose-treated podocytes.
Nesfatin-1 (zeige NUCB2 Antikörper) promotes the differentiation of brown adipocytes likely through the mTOR dependent mechanism.
Inhibition of mammalian target of rapamycin (mTOR) activation using rapamycin restored Mb mRNA expression to control levels. Lipid supplementation had no effect on Mb gene expression. Thus, IGF-1 (zeige IGF1 Antikörper)-induced anabolic signaling can be a strategy to improve muscle size under mild hypoxia, but lowers Mb gene expression
These results demonstrate that mTOR acts as a molecular rheostat of natural killer cell reactivity controlled by educating receptors and uncover how cytokine stimulation overcomes natural killer cell education.
ResultsPIA suppressed phosphorylation of all mTOR proteins
MTOR plays a critical role in the regulation of cortical interneuron number and autophagy in the developing brain.
in the central nervous systems (CNS), the mammalian target of rapamycin (mTOR) pathway plays a critical role in regulating the regenerative capacity of neurons.
This study reveals the dramatic rescue effects of L-leucine stimulation of mTORC1 in RBS (zeige ESCO2 Antikörper) cells and supports that normal gene expression and translation requires ESCO2 (zeige ESCO2 Antikörper) function.
By inhibiting mTOR signaling via Fbxw7 (zeige FBXW7 Antikörper), the amount of myelination during development is reduced.
Apc mutations activate mechanistic target of rapamycin complex 1 in mice and zebrafish
In our zebrafish model, autophagy induction does not depend on inhibition of the Tor pathway or activation of Tp53 (zeige TP53 Antikörper).
TOR signaling is a common pathological pathway that can be leveraged for therapeutic benefits in cardiomyopathies of different origins.
in addition to regulating cell growth and proliferation, TOR signaling controls the developmental program guiding epithelial morphogenesis in the intestine
The immunoprecipitation results also showed that high AA concentrations significantly increased the interaction of mTOR and PPARg (zeige PPARG Antikörper). In summary, PPARg (zeige PPARG Antikörper) plays an important role in the regulation of IGF-1 (zeige IGF1 Antikörper) secretion and gene expression in response to dietary protein.
These results indicate glycine enhances muscle protein mass under an inflammatory condition. The beneficial roles of glycine on the muscle are closely associated with maintaining Akt (zeige AKT1 Antikörper)-mTOR-FOXO1 (zeige FOXO1 Antikörper) signaling and suppressing the activation of TLR4 (zeige TLR4 Antikörper) and/or NOD2 (zeige NOD2 Antikörper) signaling pathways.
Data show that the amount of proteins related to mechanistic target of rapamycin (mTOR) signaling pathways decreased along crypt-villus axis (CVA).
AMPK (zeige PRKAA1 Antikörper)-mTOR-autophagy signaling is altered by intrauterine growth restriction in newborn piglets.
Uroguanylin (zeige GUCA2B Antikörper) modulates (Na++K+)ATPase (zeige ATP1A1 Antikörper) in a proximal tubule cells via cGMP/protein kinase (zeige CDK7 Antikörper) G, cAMP/protein kinase A, and mTOR pathways.
mTOR is involved in 17beta-estradiol-induced, cultured immature boar Sertoli cell proliferation via regulating the expression of SKP2, CCND1 (zeige CCND1 Antikörper), and CCNE1 (zeige CCNE1 Antikörper).
L-Glutamine (zeige GFPT2 Antikörper) enhances enterocyte growth via activation of the mTOR.
Arg, Leu, and Gln act coordinately to stimulate proliferation of pTr (zeige PTCHD3 Antikörper) cells through activation of the MTOR-RPS6K-RPS6 (zeige RPS6 Antikörper)-EIF4EBP1 (zeige EIF4EBP1 Antikörper) signal transduction pathway.
Data indicate that the expression of MAP1LC3A (zeige MAP1LC3A Antikörper), B and autophagy-associated genes (ATG5 (zeige ATG5 Antikörper), mTOR, Beclin-1 (zeige BECN1 Antikörper)) was increased in normal pigs, while decreased in miniature pigs.
Biochemical, cellular, and molecular data suggest that L-arginine (zeige GATM Antikörper) stimulates mTOR biosynthesis, mTOR signaling, and overall protein biosynthesis/turnover in placental/trophoblast and blastocyst/ectoderm cells thereby enhancing cell proliferation.
AnxA2 (zeige ANXA2 Antikörper) functions as a critical regulator for amino acid or hormone-induced milk synthesis and mammary gland epithelial cell proliferation via the PI3K-mTOR-SREBP-1c (zeige SREBF1 Antikörper)/Cyclin D1 (zeige CCND1 Antikörper) signaling pathway.
These findings suggest that mTOR is involved in the control of the expression of multiple genes in cattle, which may be triggered by the luteinizing hormone surge.
14-3-3gamma (zeige YWHAG Antikörper) affects mTOR protein pathway and regulates lactogenesis in dairy cow mammary epithelial cells.
Methionine promoted casein synthesis, and this may be mediated by enhanced intracellular substrate availability and by activating JAK2 (zeige JAK2 Antikörper)-STAT5 (zeige STAT5A Antikörper) and mTOR signaling pathways.
Insulin (zeige INS Antikörper)-induced activation of phosphoinositide 3-kinase~mTOR pathway up-regulates tau protein via acceleration of protein synthesis in adrenal chromaffin cells, promoting neurite-like process outgrowth.
IGF-I (zeige IGF1 Antikörper) down-regulated functional IGF-I receptor (zeige IGF1R Antikörper) via GSK-3beta inhibition and mTOR activation; constitutive activity of GSK-3beta maintained IGF-I receptor (zeige IGF1R Antikörper) level in nonstimulated cells.
stimulation of mammary protein synthesis by amino acids and its enhancement by a combination of the lactogenic hormones hydrocortisone, insulin (zeige INS Antikörper), and prolactin (zeige PRL Antikörper) were associated with increased phosphorylation of the mTOR substrates
data demonstrate that hypoxia-induced adventitial fibroblast proliferation requires activation and interaction of PI3K, Akt, mTOR, p70S6K, and ERK1/2.
prostaglandin F2alpha phosphorylates TSC2 (zeige TSC2 Antikörper) and activates mTOR and ribosomal protein S6 (zeige RPS6 Antikörper) kinase (zeige RPS6KB1 Antikörper) signaling in an AKT (zeige AKT1 Antikörper)-independent manner
mTOR links IGF-I (zeige IGF1 Antikörper) and EGF (zeige EGF Antikörper) signaling in inhibiting the autophagy pathways.
The protein encoded by this gene belongs to a family of phosphatidylinositol kinase-related kinases. These kinases mediate cellular responses to stresses such as DNA damage and nutrient deprivation. This protein acts as the target for the cell-cycle arrest and immunosuppressive effects of the FKBP12-rapamycin complex. The ANGPTL7 gene is located in an intron of this gene.
FK506 binding protein 12-rapamycin associated protein 1
, FK506 binding protein 12-rapamycin associated protein 2
, FK506-binding protein 12-rapamycin complex-associated protein 1
, FKBP-rapamycin associated protein
, FKBP12-rapamycin complex-associated protein 1
, mammalian target of rapamycin
, rapamycin and FKBP12 target 1
, rapamycin associated protein FRAP2
, rapamycin target protein 1
, serine/threonine-protein kinase mTOR
, FKBP-rapamycin associated protein (FRAP)
, FKBP-rapamycin-associated protein FRAP
, FKBP12-rapamycin complex-associated protein
, angiopoietin-like factor CDT6
, rapamycin and FKBP12 target-1 protein
, target of rapamycin